VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $313 | -61.0% | 33,398 | +2.0% | 0.00% | -60.0% |
| Q2 2023 | $803 | -5.9% | 32,742 | -10.7% | 0.01% | 0.0% |
| Q1 2023 | $853 | -1.2% | 36,646 | +7.5% | 0.01% | -16.7% |
| Q4 2022 | $863 | -99.9% | 34,103 | +7.0% | 0.01% | +20.0% |
| Q3 2022 | $615,000 | -75.1% | 31,880 | -67.1% | 0.01% | -70.6% |
| Q2 2022 | $2,468,000 | -17.8% | 96,887 | -17.0% | 0.02% | -5.6% |
| Q1 2022 | $3,003,000 | -47.1% | 116,750 | -13.9% | 0.02% | -40.0% |
| Q4 2021 | $5,675,000 | -70.0% | 135,529 | -68.8% | 0.03% | -74.4% |
| Q3 2021 | $18,894,000 | +19.1% | 434,156 | +29.4% | 0.12% | +15.8% |
| Q2 2021 | $15,863,000 | +22.8% | 335,512 | +33.1% | 0.10% | +4.1% |
| Q1 2021 | $12,920,000 | +228.8% | 251,996 | +71.7% | 0.10% | +203.1% |
| Q4 2020 | $3,930,000 | +297.4% | 146,751 | +409.4% | 0.03% | +220.0% |
| Q3 2020 | $989,000 | – | 28,806 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |